SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...
MedPage Today on MSN
Liver cancer treatment landscape shifts rapidly, but best sequencing still unclear
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.
People coinfected with HIV and hepatitis C virus remain at risk for hepatocellular carcinoma within 6 years of starting ...
Liver cancer remains one of the deadliest cancers worldwide, something that escapes early detection. Understand liver cancer, ...
Please provide your email address to receive an email when new articles are posted on . At least 60% of liver cancer diagnoses can be attributed to modifiable risk factors. Alcohol consumption and ...
MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback